Targetmol

Minimycin, with the CAS number 32388-21-9, is an antibiotic compound that belongs to the class of tetracyclines. It exhibits broad-spectrum antibacterial activity, making it effective against a variety of Gram-positive and Gram-negative bacteria. The mechanism of action involves the inhibition of protein synthesis by binding to the bacterial ribosome, which prevents the growth and reproduction of bacteria. Minimycin is known for its stability in the presence of acids and its relatively low toxicity compared to other antibiotics in its class. It is often used in veterinary medicine and has potential applications in treating certain infections in humans. The compound's pharmacokinetics, including absorption, distribution, metabolism, and excretion, are important for determining its efficacy and safety profile. As with other antibiotics, the development of resistance is a concern, necessitating careful use and consideration of alternative therapies when appropriate. Overall, Minimycin represents a valuable tool in the fight against bacterial infections, although its use should be guided by susceptibility patterns and clinical guidelines.

Minimycin

32388-21-9: Minimycin, with the CAS number 32388-21-9, is an antibiotic compound that belongs to the class of tetracyclines. It exhibits broad-spectrum antibacterial activity, making it effective against a variety of Gram-positive and Gram-negative bacteria. The mechanism of action involves the inhibition of protein synthesis by binding to the bacterial ribosome, which prevents the growth and reproduction of bacteria. Minimycin is known for its stability in the presence of acids and its relatively low toxicity compared to other antibiotics in its class. It is often used in veterinary medicine and has potential applications in treating certain infections in humans. The compound's pharmacokinetics, including absorption, distribution, metabolism, and excretion, are important for determining its efficacy and safety profile. As with other antibiotics, the development of resistance is a concern, necessitating careful use and consideration of alternative therapies when appropriate. Overall, Minimycin represents a valuable tool in the fight against bacterial infections, although its use should be guided by susceptibility patterns and clinical guidelines.

Minimycin (Oxazinomycin) is a nucleoside antibiotic with broad-spectrum antibacterial properties. It exhibits inhibitory effects on Ehrlich ascites carcinoma as well as both ascitic and solid forms of sarcoma-180 in mice.

CAS 32388-21-9

Minimycin

Minimycin

Ref: TR-M721000

Minimycin

Ref: TM-TN9841